These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 1658045)

  • 21. L-arginine administration normalizes pressure natriuresis in hypertensive Dahl rats.
    Patel A; Layne S; Watts D; Kirchner KA
    Hypertension; 1993 Dec; 22(6):863-9. PubMed ID: 8244518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of new inbred strains of Dahl-Iwai salt-sensitive and salt-resistant rats.
    Yamazaki K; Katoh H; Yamamoto N; Kurihara K; Iobe H; Sonoda J; Kuwabara M; Kodama M; Kawaguchi A; Funami Y
    Lab Anim Sci; 1994 Oct; 44(5):462-7. PubMed ID: 7844954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of nitric oxide in the NKCC2 hyperactivity of Dahl "salt-sensitive" rats].
    Alvarez-Guerra M; Lou M; Garay RP
    Arch Mal Coeur Vaiss; 2004; 97(7-8):731-3. PubMed ID: 15506055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baroreflex control of heart rate in young and adult salt hypertensive inbred Dahl rats.
    Nedvídek J; Zicha J
    Physiol Res; 2000; 49(3):323-30. PubMed ID: 11043919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
    Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
    J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension.
    Johnson FK; Johnson RA; Peyton KJ; Durante W
    Am J Physiol Regul Integr Comp Physiol; 2005 Apr; 288(4):R1057-62. PubMed ID: 15591155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.
    Calver A; Collier J; Moncada S; Vallance P
    J Hypertens; 1992 Sep; 10(9):1025-31. PubMed ID: 1328361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced arteriolar vasomotion in rats with chronic salt-induced hypertension.
    Boegehold MA
    Microvasc Res; 1993 Jan; 45(1):83-94. PubMed ID: 8479344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of chronic increased salt intake on nitric oxide synthesis inhibition-induced hypertension.
    Fernández-Rivas A; García-Estañ J; Vargas F
    J Hypertens; 1995 Jan; 13(1):123-8. PubMed ID: 7759842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interrelationship between TGF-beta1 and nitric oxide is altered in salt-sensitive hypertension.
    Ying WZ; Sanders PW
    Am J Physiol Renal Physiol; 2003 Nov; 285(5):F902-8. PubMed ID: 12865256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of decreased tubular flow-induced nitric oxide in Dahl salt-sensitive rat thick ascending limbs.
    Hong NJ; Gonzalez-Vicente A; Saez F; Garvin JL
    Am J Physiol Renal Physiol; 2021 Sep; 321(3):F369-F377. PubMed ID: 34308669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of a calcium-enriched diet on salt-induced hypertension in rats.
    Garthoff B; Kazda S
    J Hypertens Suppl; 1985 Dec; 3(3):S433-4. PubMed ID: 2856758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats.
    Uehara Y; Hirawa N; Numabe A; Kawabata Y; Ikeda T; Gomi T; Gotoh A; Omata M
    Am J Hypertens; 1997 May; 10(5 Pt 2):83S-88S. PubMed ID: 9160787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered nitric oxide production and exogenous nitric oxide do not affect the proliferation of rat mesangial cells.
    Mohaupt M; Schoecklmann HO; Schulze-Lohoff E; Sterzel RB
    J Hypertens; 1994 Apr; 12(4):401-8. PubMed ID: 8064164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide synthase isotype expression in salt-sensitive and salt-resistant Dahl rats.
    Ni Z; Oveisi F; Vaziri ND
    Hypertension; 1999 Oct; 34(4 Pt 1):552-7. PubMed ID: 10523325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of blood pressure salt-sensitivity supports a preglomerular site of action of nitric oxide in Type I diabetic rats.
    Brands MW; Bell TD; Fleming C; Labazi H; Sturgis LC
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):475-9. PubMed ID: 17439418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension.
    Tian N; Rose RA; Jordan S; Dwyer TM; Hughson MD; Manning RD
    J Hypertens; 2006 Nov; 24(11):2263-70. PubMed ID: 17053549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced influence of nitric oxide on arteriolar tone in hypertensive Dahl rats.
    Boegehold MA
    Hypertension; 1992 Mar; 19(3):290-5. PubMed ID: 1548054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
    Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
    Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension.
    Tian N; Thrasher KD; Gundy PD; Hughson MD; Manning RD
    Hypertension; 2005 May; 45(5):934-9. PubMed ID: 15837840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.